UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 6-K
REPORT OF FOREIGN PRIVATE ISSUER
PURSUANT TO SECTION 13A-16 OR 15D-16
UNDER THE SECURITIES EXCHANGE ACT OF 1934
For the month of October 2025
Commission File Number: 001-42020
MAREX GROUP PLC
(Translation of registrant’s name into English)
|
|
|
155 Bishopsgate
London EC2M 3TQ United
Kingdom +44 20 7655 6000 |
|
140 East 45th Street, 10th Floor
New York, New York 10017
(212) 618-2800 |
(Address of Principal Executive Offices)
Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.
Form 20-F ☒ Form 40-F ☐
EXPLANATORY NOTE
Marex Group plc Preliminary Q3 2025 Update
On
8 October 2025, Marex Group plc (the “Company”) issued a press release titled “Marex Group plc provides a strong preliminary Q3 trading update”. A copy of the press release is furnished as Exhibit 99.1 herewith.
EXHIBIT INDEX
The following exhibit is furnished as part of this Form 6-K:
|
|
|
Exhibit No. |
|
Description |
|
|
99.1 |
|
Press release dated 8 October 2025 titled “Marex Group plc provides a strong preliminary Q3 trading update” |
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned,
thereunto duly authorized.
|
|
|
|
|
|
|
|
|
|
|
Marex Group plc |
|
|
|
|
Date: 8 October 2025 |
|
|
|
By: |
|
/s/ Robert Irvin |
|
|
|
|
|
|
Robert Irvin |
|
|
|
|
|
|
Chief Financial Officer |